AJTMH HINARI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am. J. Trop. Med. Hyg., 65(2), 2001, pp. 90-93
Copyright © 2001 by The American Society of Tropical Medicine and Hygiene

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Soto, J
Right arrow Articles by Berman, J
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Soto, J
Right arrow Articles by Berman, J
Related Collections
Right arrow Travel Medicine
Right arrow Malaria
American Journal of Tropical Medicine and Hygiene, Vol 65, Issue 2, 90-93
Copyright © 2001 by American Society of Tropical Medicine and Hygiene

Research Articles


Plasmodium vivax clinically resistant to chloroquine in Colombia

J Soto, J Toledo, P Gutierrez, M Luzz, N Llinas, N Cedeno, M Dunne, and J Berman

Chloroquine-resistant Plasmodium vivax has been the subject of numerous case reports and prospective studies from Oceania and Asia. In contrast, only case reports exist from the Americas. We performed a prospective study with 28-day follow-up of clinical responses to chloroquine in 2 P. vivax-endemic regions of Colombia. Three (11%) of 27 patients failed to respond to treatment with the standard regimen of chloroquine (1,500 mg of base over 3 days). One patient demonstrated RI resistance on Day 26; one patient demonstrated RI resistance due to recrudescence of blood stages on Day 11; and one patient demonstrated RII resistance of blood stages by never displaying clearing of peripheral parasitemia. All patients were successfully treated with primaquine, which has some blood stage efficacy against P. vivax, combined with a second course of chloroquine. Clinical resistance of P. vivax to chloroquine is present in Colombia and should be monitored in the Americas.


This article has been cited by other articles:


Home page
Clin. Microbiol. Rev.Home page
J. K. Baird
Resistance to Therapies for Infection by Plasmodium vivax
Clin. Microbiol. Rev., July 1, 2009; 22(3): 508 - 534.
[Abstract] [Full Text] [PDF]


Home page
Am J Trop Med HygHome page
K. Chotivanich, J. Sattabongkot, Y. K. Choi, J. S. Park, J. Sritabal, C. S. Lim, R. Udomsangpetch, N. J. White, and W. J. Lee
Antimalarial Drug Susceptibility of Plasmodium vivax in the Republic of Korea
Am J Trop Med Hyg, June 1, 2009; 80(6): 902 - 904.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
A. R. Hasugian, E. Tjitra, A. Ratcliff, H. Siswantoro, E. Kenangalem, R. M. Wuwung, H. L. E. Purba, K. A. Piera, F. Chalfien, J. Marfurt, et al.
In Vivo and In Vitro Efficacy of Amodiaquine Monotherapy for Treatment of Infection by Chloroquine-Resistant Plasmodium vivax
Antimicrob. Agents Chemother., March 1, 2009; 53(3): 1094 - 1099.
[Abstract] [Full Text] [PDF]


Home page
Am J Trop Med HygHome page
K. S. Lee, T. H. Kim, E. S. Kim, H.-S. Lim, J.-S. Yeom, G. Jun, and J.-W. Park
Chloroquine-resistant Plasmodium vivax in the Republic of Korea
Am J Trop Med Hyg, February 1, 2009; 80(2): 215 - 217.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
C. Barnadas, A. Ratsimbasoa, M. Tichit, C. Bouchier, M. Jahevitra, S. Picot, and D. Menard
Plasmodium vivax Resistance to Chloroquine in Madagascar: Clinical Efficacy and Polymorphisms in pvmdr1 and pvcrt-o Genes
Antimicrob. Agents Chemother., December 1, 2008; 52(12): 4233 - 4240.
[Abstract] [Full Text] [PDF]


Home page
Am J Trop Med HygHome page
S. Pukrittayakamee, M. Imwong, P. Singhasivanon, K. Stepniewska, N. J. Day, and N. J. White
Effects of Different Antimalarial Drugs on Gametocyte Carriage in P. Vivax Malaria
Am J Trop Med Hyg, September 1, 2008; 79(3): 378 - 384.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
B. Russell, F. Chalfein, B. Prasetyorini, E. Kenangalem, K. Piera, R. Suwanarusk, A. Brockman, P. Prayoga, P. Sugiarto, Q. Cheng, et al.
Determinants of In Vitro Drug Susceptibility Testing of Plasmodium vivax
Antimicrob. Agents Chemother., March 1, 2008; 52(3): 1040 - 1045.
[Abstract] [Full Text] [PDF]


Home page
Am J Trop Med HygHome page
R. N. Price, E. Tjitra, C. A. Guerra, S. Yeung, N. J. White, and N. M. Anstey
Vivax Malaria: Neglected and Not Benign
Am J Trop Med Hyg, December 1, 2007; 77(6_Suppl): 79 - 87.
[Abstract] [Full Text] [PDF]


Home page
Am J Trop Med HygHome page
G. ALVAREZ, J.-G. PINEROS, A. TOBON, A. RIOS, A. MAESTRE, S. BLAIR, and J. CARMONA-FONSECA
Efficacy of three chloroquine-primaquine regimens for treatment of Plasmodium vivax malaria in Colombia.
Am J Trop Med Hyg, October 1, 2006; 75(4): 605 - 609.
[Abstract] [Full Text] [PDF]


Home page
Am J Trop Med HygHome page
M. W. DUNNE, N. SINGH, M. SHUKLA, N. VALECHA, P. C. BHATTACHARYYA, K. PATEL, M. K. MOHAPATRA, J. LAKHANI, C. U. DEVI, T. ADAK, et al.
A DOUBLE-BLIND, RANDOMIZED STUDY OF AZITHROMYCIN COMPARED TO CHLOROQUINE FOR THE TREATMENT OF PLASMODIUM VIVAX MALARIA IN INDIA
Am J Trop Med Hyg, December 1, 2005; 73(6): 1108 - 1111.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
M. D. Hastings, J. D. Maguire, M. J. Bangs, P. A. Zimmerman, J. C. Reeder, J. K. Baird, and C. H. Sibley
Novel Plasmodium vivax dhfr Alleles from the Indonesian Archipelago and Papua New Guinea: Association with Pyrimethamine Resistance Determined by a Saccharomyces cerevisiae Expression System
Antimicrob. Agents Chemother., February 1, 2005; 49(2): 733 - 740.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
J. K. Baird
Chloroquine Resistance in Plasmodium vivax
Antimicrob. Agents Chemother., November 1, 2004; 48(11): 4075 - 4083.
[Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
S. Brega, F. de Monbrison, C. Severini, R. Udomsangpetch, I. Sutanto, P. Ruckert, F. Peyron, and S. Picot
Real-Time PCR for Dihydrofolate Reductase Gene Single-Nucleotide Polymorphisms in Plasmodium vivax Isolates
Antimicrob. Agents Chemother., July 1, 2004; 48(7): 2581 - 2587.
[Abstract] [Full Text] [PDF]


Home page
Am J Trop Med HygHome page
K. CHOTIVANICH, R. UDOMSANGPETCH, W. CHIERAKUL, P. N. NEWTON, R. RUANGVEERAYUTH, S. PUKRITTAYAKAMEE, S. LOOAREESUWAN, and N. J. WHITE
IN VITRO EFFICACY OF ANTIMALARIAL DRUGS AGAINST PLASMODIUM VIVAX ON THE WESTERN BORDER OF THAILAND
Am J Trop Med Hyg, April 1, 2004; 70(4): 395 - 397.
[Abstract] [Full Text] [PDF]


Home page
Am J Trop Med HygHome page
T. K. RUEBUSH II, J. ZEGARRA, J. CAIRO, E. M. ANDERSEN, M. GREEN, D. R. PILLAI, W. MARQUINO, M. HUILCA, E. AREVALO, C. GARCIA, et al.
CHLOROQUINE-RESISTANT PLASMODIUM VIVAX MALARIA IN PERU
Am J Trop Med Hyg, November 1, 2003; 69(5): 548 - 552.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
J. P. Daily and M. A. Waldron
Case 22-2003 - A 22-Year-Old Man with Chills and Fever after a Stay in South America
N. Engl. J. Med., July 17, 2003; 349(3): 287 - 295.
[Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. D. Hastings and C. H. Sibley
Pyrimethamine and WR99210 exert opposing selection on dihydrofolate reductase from Plasmodium vivax
PNAS, October 1, 2002; 99(20): 13137 - 13141.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the American Society of Tropical Medicine and Hygiene.